Strength in Numbers dedicated to my late mother Kay

NHS says no to new breast cancer drug Kadcyla – Are you affected by the Kadcyla decision?

A pioneering new breast cancer treatment will not be routinely available in England and Wales, the NHS drugs advisory body NICE is proposing.
The drug – Kadcyla – adds six months of life on average to women dying with an aggressive form of breast cancer.
NICE criticised makers Roche for not setting an affordable price, in its updated draft guidance.
The drug costs £90,000 per patient but Roche said it had offered a lower – undisclosed – price in recent talks.
The two organisations have been in negotiations since the first draft guidance from NICE (the National Institute for Health and Care Excellence), rejecting the drug, was published in April.

Click on the link to read more

Are you affected by the Kadcyla decision? Sensitive C4 documentary wants to hear from you. email : health@voltage.tu


Filed under: Uncategorized, , ,

One Response

  1. hanhall says:

    I’m so glad this has been highlighted. Read my post about the impact of the decision on me in my post


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: